
Releases
Robbins LLP Files Class Action Following Grail Stock Price Collapse
Investors who bought Grail, Inc. securities between May 13, 2025, and February 19, 2026, are being urged to contact Robbins LLP. The firm has initiated a class action lawsuit alleging the healthcare company misled shareholders regarding the clinical potential of its early cancer detection screening methodology, the NHS-Galleri test.






















